Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B
NCT01205165Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by GSK. Primary endpoint: Mean Log 10 Reduction in Serum Hepatitis B Virus (HBV) DNA Level From Baseline to Week 12. Started Dec 2004; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01205165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01205165.